Showing results (241-250 of 381) with videos related to
Sort By:
Pageof 39
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 26, 2022
Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registryLu Zhou, Liu He, Wei Wang, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 3, 2021
Improving Anticoagulant Treatment Strategies of Atrial Fibrillation Using Reinforcement LearningLei Zuo, Xin Du, Wei Zhao, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2015
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: two-year results from a prospective patient-level pooled analysis of TARGET trialsZhan Gao, Ruiyan Zhang, Bo Xu, et al.Frontiers in Cardiovascular Medicine|July 11, 2022
Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial FibrillationYiwei Lai, Manlin Zhao, Chao Jiang, et al.European Journal of Preventive Cardiology|January 29, 2025
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidenceJiaju Li, Yiwei Lai, Chao Jiang, et al.Journal of Hypertension|May 1, 2024
Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial studyZhiyan Wang, Wenjie Li, Chao Jiang, et al.Hypertension (Dallas, Tex. : 1979)|January 2, 2024
Effect of Intensive Blood Pressure Control on Cardiovascular Outcomes in Cancer SurvivorsWenjie Li, Zhiyan Wang, Chao Jiang, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 10, 2014
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillationGerald V Naccarelli, Riccardo Cappato, Stefan H Hohnloser, et al.Journal of the American College of Cardiology|November 3, 2022
Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial InfarctionWei Gong, Yan Yan, Xiao Wang, et al.Medicine|August 10, 2020
A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertensionJiahui Wu, Xin Du, Qiang Lv, et al.Pageof 39